AI Mental Health Monitoring Wristband Receives FDA Approval: Can Predict Depressive Episodes 72 Hours in Advance
Mindstrong Health's AI wristband monitors skin conductance, heart rate variability, and sleep patterns to predict depressive episodes 72 hours in advance. Received FDA Class II medical device certification.
AI Mental Health Monitoring Wristband Receives FDA Approval: Can Predict Depressive Episodes 72 Hours in Advance
Mindstrong Health announced on March 3 that its AI mental health monitoring wristband MindWave has received FDA Class II medical device certification. The wristband continuously monitors skin conductance, heart rate variability (HRV), skin temperature, and movement patterns, using machine learning models to assess the wearer's emotional state.
Clinical trial data showed MindWave can predict major depressive episodes 72 hours in advance with 81% accuracy. When the device detects abnormal patterns, it sends alerts to both the user and their designated emergency contact, and suggests the user reach out to a mental health professional.
Mindstrong Health CEO Paul Dagum said: 'The biggest challenge in mental health is that people often only seek help after an episode. MindWave's goal is to provide a warning before the crisis arrives.'
The wristband is priced at $299 with a companion app subscription of $14.99/month. The American Psychological Association expressed cautious support for the device but reminded users it should not substitute for professional diagnosis.
Disclaimer
Content is AI-generated. Do not use it as a basis for real decisions. Do not cite it as factual reporting.